Healthcare Sales & Marketing Network News: fertility

Searching News Database: fertility

HSMN NewsFeed - 20 Dec 2024
Neurocrine Biosciences Announces Commercial Availability of CRENESSITY(TM) (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia
Biopharmaceuticals Product Launch

HSMN NewsFeed - 28 Jun 2024
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY(R)) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 17 Aug 2023
AbbVie Announces European Commission Approval of AQUIPTA(R) (atogepant) for the Preventive Treatment of Migraine in Adults
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 18 Oct 2022
FDA Approves First IND of its Kind for Allogenic Exosomal Treatment of Female Reproductive Disorder - Primary Ovarian Insufficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Aug 2022
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Jul 2022
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO(R) (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 4 May 2022
Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise
Diagnostics FDA

HSMN NewsFeed - 4 Apr 2022
FDA approves Nobelpharma's HYFTOR(TM) (sirolimus topical gel) 0.2%
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Oct 2021
FDA Approves Verzenio(R) (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 30 Aug 2021
Visby Medical(TM) Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test
Diagnostics FDA

HSMN NewsFeed - 3 Aug 2021
SynOx Therapeutics Further Strengthens Team with Appointments of Chief Medical Officer and Chief Technology Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Jul 2021
SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 25 Jan 2021
Eiger BioPharmaceuticals Announces U.S. Commercial Availability of Zokinvy(TM) (lonafarnib), the First and Only Treatment Approved for Progeria and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals Product Launch

HSMN NewsFeed - 11 Dec 2020
BAVENCIO(R) (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 25 Nov 2020
Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy(TM) (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 1 Sep 2020
MedGyn Completes Acquisition of Thomas Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 25 Aug 2020
FDA Accepts Filing of New Drug Application for Tepotinib for the Treatment of Patients with Metastatic NSCLC with METex14 Skipping Alterations
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Aug 2020
Lupin Presents Phase 3 Data for Solosec(R) (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis
Biopharmaceuticals

HSMN NewsFeed - 21 May 2020
Activ Surgical Appoints Sub Datta as COO
Devices Surgery Personnel

HSMN NewsFeed - 9 Apr 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Mar 2020
INVOcell Appoints Yve Lyppens as Director Business Development Asia Pacific
Devices Personnel

HSMN NewsFeed - 13 Feb 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
Devices Personnel

HSMN NewsFeed - 10 Feb 2020
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 8 Jan 2020
Aruvant Receives FDA Rare Pediatric Disease Designation for ARU-1801 for the Treatment of Sickle Cell Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Sep 2019
Healogics(R) Names Rob Doll as New Chief Marketing Officer
Devices Wound Care Personnel

HSMN NewsFeed - 12 Aug 2019
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
Diagnostics FDA

HSMN NewsFeed - 30 Jul 2019
Lilly's Verzenio(R) (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Jan 2019
INVO Bioscience Closes Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell(TM) System for Use in the Treatment of Infertility
Biopharmaceuticals Licensing

HSMN NewsFeed - 18 Dec 2018
Lilly Announces Publication of Analyses Showing Benefit of the Addition of Verzenio(R) (Abemaciclib) in Multiple Subgroups of Patients with Advanced Breast Cancer Identified as Having a More Concerning Prognosis
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Nov 2018
FDA Accepts Filing of New Estrogen-free Oral Contraceptive Developed by Exeltis
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Nov 2018
Indivior Announces Health Canada Approval of SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for Patients with Moderate to Severe Opioid Use Disorder
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Oct 2018
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 24 Sep 2018
Quest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 31 Aug 2018
Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Aug 2018
Siklos(R), the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in retail pharmacies
Biopharmaceuticals Product Launch

HSMN NewsFeed - 17 Aug 2018
Eisai And Merck Announce FDA Approval Of LENVIMA(R) (lenvatinib) Capsules For First-Line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Aug 2018
US Food And Drug Administration (FDA) Clears Natural Cycles As The First Digital Method Of Birth Control In The United States
Devices Diagnostics FDA Product Launch

HSMN NewsFeed - 27 Jul 2018
Accord Healthcare’s (Intas) Pelgraz(R) (pegfilgrastim) Given Green Light by CHMP
Biopharmaceuticals Generics Oncology Regulatory

HSMN NewsFeed - 2 Jul 2018
Phase III IMpassion130 Study Showed Genentech's TECENTRIQ Plus Abraxane Significantly Reduced the Risk of Disease Worsening or Death in People With Metastatic or Locally Advanced Triple Negative Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Jun 2018
FDA Expands Lilly's ALIMTA(R) (pemetrexed) Label to Include Combination with KEYTRUDA(R) (pembrolizumab) and Carboplatin as First-Line Treatment for Metastatic Nonsquamous Non-Small Cell Lung Cancer, Irrespective of PD-L1 Expression
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 16 Apr 2018
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
Diagnostics FDA

HSMN NewsFeed - 23 Mar 2018
Amgen Receives Positive CHMP Opinion Recognizing That Repatha(R) (evolocumab) Prevents Heart Attacks And Strokes
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 15 Mar 2018
DxNow, Inc. Receives FDA 510(k) Clearance for ZyMōt(TM) ICSI and ZyMōt(TM) Multi Sperm Separation Devices
Devices FDA

HSMN NewsFeed - 6 Mar 2018
Wendy Sussman Joins EMD Serono as Vice President of U.S. Healthcare Government & Public Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jan 2018
Independent Imaging Review Confirmed Positive Data from Primary Analysis of REFLECT Trial Evaluating Lenvatinib Compared to Sorafenib in Unresectable Hepatocellular Carcinoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Dec 2017
Aytu BioScience Announces Appointment of David Green as Chief Financial Officer
Biopharmaceuticals Urology Personnel

HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2017
Lia Diagnostics Announces FDA Clearance Of The First And Only Flushable, Biodegradable Pregnancy Test
Diagnostics FDA

HSMN NewsFeed - 5 Dec 2017
EMD Serono Announces FDA 510(k) Clearance of Partner Genea Biomedx's Fertility Benchtop Incubator Geri(TM)
Devices FDA

HSMN NewsFeed - 1 Dec 2017
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2017
EMD Serono Receives FDA Approval for New GONAL-f(R) RFF Redi-ject(R) Pen
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 10 Nov 2017
Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 26 Oct 2017
Aytu BioScience Provides Quarterly Update on the Natesto(R) U.S. Launch
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 23 Oct 2017
EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Oct 2017
FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio(TM) (abemaciclib) as Initial Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 10 Oct 2017
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Oct 2017
Aytu BioScience Announces International Distribution Agreement for Fiera(R) in Japan
Biopharmaceuticals Urology Distribution

HSMN NewsFeed - 7 Aug 2017
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 7 Aug 2017
Impax Announces Settlement of Contract Litigation on Opana(R) ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets
Biopharmaceuticals Litigation

HSMN NewsFeed - 13 Jul 2017
Aytu BioScience Expands MiOXSYS(R) Distribution Network with a Fertility-Focused Company in Over 20 Countries in Europe
Diagnostics Urology Distribution

HSMN NewsFeed - 31 May 2017
Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA(R) (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 May 2017
Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 28 Apr 2017
Novartis Receives FDA Approval for Rydapt(R) in Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) and Three Types of Systemic Mastocytosis (SM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Apr 2017
FDA Approves XATMEP(TM), the First and Only Ready-To-Use Methotrexate Oral Solution
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Mar 2017
Surgery Without the Knife: Mirabilis Medical Announces European Approval for Non-Invasive Uterine Fibroid Treatment
Devices Regulatory

HSMN NewsFeed - 24 Mar 2017
FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA Product Launch

HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Feb 2017
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 2 Feb 2017
Daxor Corporation Announces Death of Founder, Chief Medical Officer, and Developer of Blood Volume Analysis and Inventor of the Daxor BVA-100 Device, Dr. Joseph Feldschuh
Diagnostics Personnel

HSMN NewsFeed - 25 Jan 2017
Myovant Sciences Initiates Phase 3 Clinical Program of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Biopharmaceuticals

HSMN NewsFeed - 17 Jan 2017
Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Biopharmaceuticals

HSMN NewsFeed - 11 Jan 2017
Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv(TM) (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis
Biopharmaceuticals

HSMN NewsFeed - 1 Dec 2016
Luye Pharma Announces the Completion of Acquisition of Acino's Transdermal Drug Delivery Systems Business
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 16 Nov 2016
Myovant Sciences Appoints Terrie Curran to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Nov 2016
Boston Scientific Acquires Resectr(TM) Tissue Resection Device from Distal Access, LLC
Devices Surgery Acquisitions

HSMN NewsFeed - 11 Nov 2016
OncBioMune Broadens Portfolio, Partners and Product with Vitel Acquisition
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 10 Nov 2016
IBRANCE(R) (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 14 Sep 2016
European Commission Approves CABOMETYX(TM) (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 29 Aug 2016
New Repatha(R) (evolocumab) Analyses Show Efficacy and Safety Across Risk Groups in Results Presented at ESC Congress 2016
Biopharmaceuticals Cardiology

HSMN NewsFeed - 9 May 2016
Allergan and Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Biopharmaceuticals

HSMN NewsFeed - 9 Mar 2016
New "See-and-Treat" Truclear(TM) Hysteroscope Improves Options for Office Hysteroscopy
Devices Product Launch

HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 2 Mar 2016
Merck KGaA, Darmstadt, Germany Initiates Phase III Study of MSB11022, a Proposed Biosimilar of Adalimumab, in Chronic Plaque Psoriasis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 9 Feb 2016
Aytu BioScience Announces First Commercial Sales for Company's MiOXSYS(TM) System for Male Infertility
Devices Urology Product Launch

HSMN NewsFeed - 12 Jan 2016
Aytu BioScience Obtains CE Marking for Company's MiOXSYS(TM) System for Male Infertility
Biopharmaceuticals Urology Regulatory

HSMN NewsFeed - 6 Jan 2016
OvaScience Names Harald F. Stock Chief Executive Officer-Elect
Devices Personnel

HSMN NewsFeed - 23 Nov 2015
ObsEva Closes CHF 60 (USD 60) Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Oct 2015
FDA Approves INSIGHTEC's Next Generation Exablate Fibroid Treatment System and Removes Requirement for Patients to be Family Complete
Devices FDA

HSMN NewsFeed - 10 Sep 2015
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 29 Jul 2015
Corvida Medical Receives FDA 510(k) Clearance for Halo(TM) Closed System Transfer Device
Devices FDA

HSMN NewsFeed - 24 Jul 2015
FDA approves Novartis drug Odomzo(R) (sonidegib) for locally advanced basal cell carcinoma (laBCC), a form of skin cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 29 Jun 2015
Aerie Pharmaceuticals Elects Julie McHugh and Michael M. du Toit to the Company’s Board of Directors
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 12 May 2015
Merck KGaA, Darmstadt, Germany, Receives FDA Fast Track Designation for Evofosfamide for the Treatment of Patients Living With Advanced Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 6 May 2015
EMD Serono Initiates Co-Promotion of XALKORI(R) (crizotinib) with Pfizer in the United States
Biopharmaceuticals Oncology Distribution

HSMN NewsFeed - 13 Apr 2015
Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years
Biopharmaceuticals Product Launch

HSMN NewsFeed - 9 Dec 2014
Zydus Launches World's First Biosimilar of Adalimumab
Biopharmaceuticals Product Launch

HSMN NewsFeed - 17 Nov 2014
First U.S. Procedures Completed With The Symphion(TM) Hysteroscopic Tissue Removal System
Devices Product Launch

HSMN NewsFeed - 14 Aug 2014
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 29 Jul 2014
Abide Therapeutics Appoints Nancy Thornberry to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jul 2014
New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance
Diagnostics FDA

HSMN NewsFeed - 22 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 15 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Jun 2014
Auxogyn Receives FDA Clearance for Its Eeva(TM) System
Devices FDA

HSMN NewsFeed - 17 Apr 2014
Nora Therapeutics Announces $18 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Apr 2014
Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 Mar 2014
New Global Initiative Aims to Improve Patient Outcomes in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Mar 2014
Merck Announces Initiation of Phase III Fertility Study with Pergoveris in Poor Ovarian Response Patients
Biopharmaceuticals

HSMN NewsFeed - 17 Feb 2014
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
Diagnostics Oncology

HSMN NewsFeed - 7 Feb 2014
Ipsen announces positive top line results from phase III clinical study of Decapeptyl(R) (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with prostate cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Jan 2014
Antares Pharma Announces Availability of OTREXUP (Methotrexate) Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis (pJIA) in Children
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 13 Jan 2014
OvaScience Provides Update on Pipeline Advancements and Commercial Plans; New Potential Fertility Treatment OvaPrime(SM) to Launch in 2015
Biopharmaceuticals

HSMN NewsFeed - 10 Jan 2014
OvaScience Announces Global Healthcare Strategist Marc Kozin Joins Company’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2014
OvaScience Appoints David Stern to Executive Vice President, Global Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Dec 2013
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 16 Dec 2013
EMD Serono's Redesigned Fertility Pen Available for Distribution in US
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 3 Oct 2013
Pfizer Inc. Announces FDA Approval of DUAVEE(TM) (conjugated estrogens/ bazedoxifene) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis [1]
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Aug 2013
EMD Serono President and Head of US Operations James Hoyes Resigns
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Aug 2013
ObsEva SA Announces CHF 32 Million Series A Funding From Leading Venture Capital Firms and a License Agreement With Merck Serono
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 26 Jun 2013
Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercialization of PLX Cells for the Treatment of CLI and IC in South Korea
Regenerative Medicine Licensing

HSMN NewsFeed - 6 May 2013
Mazor Robotics Receives Second Renaissance System Order from India Business Partner Advanced Medical Systems
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 13 Mar 2013
Covidien Launches Three New Hernia Care Products at American Hernia Society Annual Meeting
Devices Surgery Product Launch

HSMN NewsFeed - 28 Feb 2013
Auxogyn Appoints Women's Health Leader, Kathryn A. Tunstall, to Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 5 Feb 2013
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna(TM) (imilecleucel-T) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 28 Jan 2013
New NCCN Guidelines for Patients(R) Available for Adolescents and Young Adults with Cancer
Biopharmaceuticals Devices Oncology

HSMN NewsFeed - 23 Jan 2013
Watson Acquires Uteron Pharma SA
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Jan 2013
Hologic Announces FDA Clearance of APTIMA Trichomonas for Use on PANTHER System
Diagnostics FDA

HSMN NewsFeed - 8 Jan 2013
Absorption Pharmaceuticals Names Laurence A. Levine, MD As The Company's Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Nov 2012
ZYTIGA(R) Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 30 Oct 2012
Richard Wolf Introduces the Smallest Bipolar Resectoscope on the Market
Devices Surgery

HSMN NewsFeed - 10 Aug 2012
Genentech Study Showed That Adding Avastin to Radiation and Chemotherapy Significantly Extended the Time People with an Aggressive Form of Brain Cancer Lived without Their Disease Worsening
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jun 2012
Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Myotonic Dystrophy
Biopharmaceuticals

HSMN NewsFeed - 14 Jun 2012
EMD Serono, Inc. Strengthens Leadership Teams with New Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jun 2012
TRUCLEAR(TM) 5.0 System offers US surgeons a patient-friendly option for removing intrauterine polyps in office or clinical setting
Devices FDA

HSMN NewsFeed - 5 Jun 2012
Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis
Biopharmaceuticals

HSMN NewsFeed - 16 May 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Apr 2012
OvaScience Secures $37 Million in Series B Financing
Regenerative Medicine Venture Capital Personnel

HSMN NewsFeed - 2 Apr 2012
Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Diganostics Venture Capital Personnel

HSMN NewsFeed - 27 Feb 2012
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 3 Feb 2012
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jan 2012
Donald Tredway MD, PhD, Joins Repros as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Nov 2011
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
Devices Distribution

HSMN NewsFeed - 9 Nov 2011
Merck Launches NEXPLANON(R) (etonogestrel implant) 68 mg in the United States – A Long-Acting Reversible Hormonal Contraceptive Effective For Up to Three Years
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 11 Oct 2011
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
Devices Surgery Regulatory

HSMN NewsFeed - 12 Sep 2011
Cook Medical Launches Otrieva(TM) Tapered Ovum Aspiration Needle for Follicle Collection
Devices

HSMN NewsFeed - 2 Aug 2011
New NCCN Patient Guidelines Help Patients Navigate the Maze of Breast Cancer Treatment Options
Oncology

HSMN NewsFeed - 6 Apr 2011
Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids
Devices Litigation

HSMN NewsFeed - 15 Mar 2011
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
Biopharmaceuticals Devices Oncology

HSMN NewsFeed - 24 Feb 2011
FDA Grants Genentech a Hearing on Avastin’s Use for Metastatic Breast Cancer in the United States
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Feb 2011
Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Jan 2011
Hologic Acquires Interlace Medical
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 16 Dec 2010
Genentech Provides Update on Avastin for Metastatic Breast Cancer Following Reviews in Europe and the United States
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Dec 2010
Watson and Richter Announce Exclusive License Agreement for Esmya
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Dec 2010
OmniGuide Announces Expansion into Gynecology Market with the Availability of the BeamPath(R)-GYN CO2 Laser Fiber
Devices Surgery

HSMN NewsFeed - 29 Sep 2010
InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
Devices Surgery

HSMN NewsFeed - 13 Sep 2010
LabCorp Enters into Definitive Agreement to Acquire Genzyme Genetics
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 13 Aug 2010
Watson Plans Q4 2010 ella(R) (ulipristal acetate) Emergency Contraceptive Launch
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Aug 2010
FDA Grants Approval of ella(R) for Emergency Contraception
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jun 2010
Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
Biopharmaceuticals

HSMN NewsFeed - 10 May 2010
Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 22 Apr 2010
Novartis Receives US FDA Approval for Zortress(R) (everolimus) to Prevent Organ Rejection in Adult Kidney Transplant Recipients
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Mar 2010
Merck Serono: Erbitux Granted Extended Use in Japan for 1st-Line Treatment of mCRC Patients with KRAS Wild-Type Tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Mar 2010
Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Mar 2010
Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 25 Feb 2010
Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Feb 2010
Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Feb 2010
Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Jan 2010
Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Jan 2010
Miraculins Announces Partnership With Inverness Medical Innovations to Develop a Diagnostic Test for Preeclampsia
Diagnostics

HSMN NewsFeed - 4 Dec 2009
Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Nov 2009
Genentech Submits Supplemental Applications to FDA for Avastin Combined with Commonly Used Chemotherapies for Women with Advanced Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Oct 2009
Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
Biopharmaceuticals Urology

HSMN NewsFeed - 18 Aug 2009
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival (PFS) in Women with Previously Treated Advanced Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Aug 2009
Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 1 Jun 2009
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 May 2009
Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
Biopharmaceuticals

HSMN NewsFeed - 11 May 2009
Debiopharm and Mepha Sign Distribution Agreement for Pamorelin(R) LA
Biopharmaceuticals Oncology Distribution

HSMN NewsFeed - 7 May 2009
Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 5 May 2009
Merck Serono Launches Glucophage Powder in First European Countries
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 21 Apr 2009
Merck Serono Launches Kuvan(R) in Europe
Biopharmaceuticals

HSMN NewsFeed - 7 Apr 2009
FDA Approves Label Change for Non-Invasive Fibroid Treatment
Devices FDA

HSMN NewsFeed - 6 Apr 2009
Bioject Announces FDA Market Clearance for the Zetajet Needle-Free Injection Therapy System
Devices Drug Delivery FDA

HSMN NewsFeed - 23 Mar 2009
Merck Serono Launches Strategic Venture Capital Fund
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Mar 2009
FIRMAGON(R) (Degarelix) is Launched in Europe for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Mar 2009
Merck and Schering-Plough to Merge
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Mar 2009
Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Feb 2009
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Feb 2009
European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva(R)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Feb 2009
European Commisssion Grants Ferring Pharmaceuticals Approval of FIRMAGON(R) (Degarelix) for Treatment of Prostate Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 3 Feb 2009
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 23 Jan 2009
Merck Serono's Oral Investigational Treatment Cladribine Tablets for Multiple Sclerosis Significantly Reduced Relapse Rate in Two-Year Phase III Pivotal Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Jan 2009
Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 9 Dec 2008
Merck Serono's Kuvan(R) Receives Marketing Authorization in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Dec 2008
Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)
Biopharmaceuticals

HSMN NewsFeed - 12 Nov 2008
Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Oct 2008
EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States
Biopharmaceuticals Licensing

HSMN NewsFeed - 22 Oct 2008
Sosei Agrees Terms With ASKA for Commercialisation of SOH-075 (NorLevo(R))
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2008
Covidien Introduces the SprayShield(TM) Adhesion Barrier System to the European Marketplace
Devices Surgery

HSMN NewsFeed - 26 Sep 2008
Merck Serono's Kuvan(R) Recommended for European Approval
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Sep 2008
Vyteris Announces Growth Initiative Through Expanded Business Development Team
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 22 Sep 2008
Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 10 Sep 2008
Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2008
Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants
Devices

HSMN NewsFeed - 8 Jul 2008
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jun 2008
New Roche Chlamydia Test Approved for Use in European Union
Diagnostics Regulatory

HSMN NewsFeed - 10 Jun 2008
Merck Serono Strengthens its Prescription Medicines Portfolio in Latin America
Biopharmaceuticals Distribution

HSMN NewsFeed - 10 Jun 2008
Merck Serono's Rebif(R) Celebrates 10th Anniversary
BIopharmaceuticals Neurology

HSMN NewsFeed - 5 Jun 2008
Merck Serono Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus
Biopharmaceuticals

HSMN NewsFeed - 13 May 2008
Vyteris Announces Appointments of President and Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 6 May 2008
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 May 2008
Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva(R) in the Treatment of Psoriasis Published in the British Journal of Dermatology
Biopharmaceuticals

HSMN NewsFeed - 29 Apr 2008
Mirabilis Completes First Human Trial of Non-Invasive Treatment for Uterine Fibroids
Devices

HSMN NewsFeed - 16 Apr 2008
Merck Announces Planned Investment of $50 Million in Research Center in the US
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2008
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2008
Positive Phase III Data Unveiled for New GnRH Blocker Degarelix
Biopharmaceuticals Urology

HSMN NewsFeed - 19 Mar 2008
Merck Serono Launches Cyanokit(R) in Japan
Biopharmaceuticals

HSMN NewsFeed - 3 Mar 2008
ContraVac Receives FDA Approval for Post-Vasectomy Home Sperm Test
Diagnostics

HSMN NewsFeed - 12 Feb 2008
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jan 2008
Duska Therapeutics Completes Corporate Office Relocation to La Jolla
Biopharmaceuticals

HSMN NewsFeed - 23 Jan 2008
Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
Diagnostics Personnel

HSMN NewsFeed - 17 Jan 2008
Stemagen First to Create Cloned Human Embryos From Adult Cells
Regenerative Medicine

HSMN NewsFeed - 20 Dec 2007
Agile Therapeutics Closes $17.6M Series E Venture Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Dec 2007
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Nov 2007
Cook Medical Delivers Innovative Treatment for Recto-Vaginal Fistulas
Devices

HSMN NewsFeed - 14 Nov 2007
Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia
Biopharmaceuticals

HSMN NewsFeed - 7 Nov 2007
Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2007
Direct Medical Systems Introduces the Smallest and Lightest Ultrasound System in the World That Will Replace the 200-Year-Old Stethoscope
Devices

HSMN NewsFeed - 31 Oct 2007
Duska Therapeutics Appoints Dr. Alan J. Tuchman to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Oct 2007
QuantRx Biomedical Corporation Announces FDA 510(k) Clearance for Its Follicle Stimulating Hormone (FSH) Immunoassay Test
Diagnostics FDA

HSMN NewsFeed - 22 Oct 2007
First-in-Man Single Port Pediatric Urological Operations Performed at Cleveland Clinic
Devices Surgery

HSMN NewsFeed - 19 Oct 2007
Actelion Ltd: Miglustat (Zavesca) Receives Negative Opinion From the European Committee For Medicinal Products For Human Use For Extension of Indication For Niemann Pick Type C
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 18 Oct 2007
Duska Therapeutics Appoints Shepard Goldberg and Steven Dinh as Board Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Oct 2007
Ikonisys Closes $30 Million Series E Financing; Investment Reflects Successful Development of Rare Cell Detection Testing Platform
Diagnostics Venture Capital

HSMN NewsFeed - 11 Oct 2007
Duska Therapeutics Appoints H. David Coherd to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Oct 2007
Immersion Medical Introduces OB/GYN Module for LaparoscopyVR(TM) Surgical Simulator
Devices Surgery

HSMN NewsFeed - 3 Oct 2007
Duska Therapeutics Names Dr. James S. Kuo as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Sep 2007
Columbia Laboratories Signs U.S. License and Supply Agreement with Ascend Therapeutics to Market PROCHIEVE(R) 4% Progesterone Gel
Biopharmaceuticals Licensing

HSMN NewsFeed - 10 Sep 2007
Aspreva Provides Update On Lupus Nephritis Development Program
Biopharmaceuticals

HSMN NewsFeed - 28 Aug 2007
Inverness Medical Innovations Agrees to Acquire Matritech, Inc.
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 22 Aug 2007
Bariatric Surgical Society Takes on New Name, New Mission and New Surgery
Surgery Endocrinology

HSMN NewsFeed - 22 Aug 2007
ViaCell Expands Study Sites in ViaCyte Pivotal Trial
Regenerative Medicine

HSMN NewsFeed - 1 Aug 2007
NCCN Updates Cervical Cancer Guidelines
Devices Oncology

HSMN NewsFeed - 1 Aug 2007
Eslax(R) (Rocuronium Bromide) Approved in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 31 Jul 2007
FDA Clears New GlucosePilot(TM) Blood Glucose Meter System
Devices Monitoring FDA Endocrinology

HSMN NewsFeed - 17 Jul 2007
Repromedix Appoints Dr. Michael J. Burns Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 17 Jul 2007
Aventir Biotech Launches New 510(k) Cleared Fecal Occult Blood Screen Test
Diagnostics FDA

HSMN NewsFeed - 29 Jun 2007
Inverness Completes Acquisition of Biosite
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 28 Jun 2007
Inverness Medical Innovations Announces FDA Clearance of the BinaxNOW(R) Malaria Antigen Detection Rapid Test
Diagnostics FDA

HSMN NewsFeed - 27 Jun 2007
Aspreva and Roche announce preliminary results for phase III study evaluating CellCept in lupus nephritis
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2007
Cook Medical Introduces Device to Naturally Prepare Pregnant Women for Labor Induction
Devices

HSMN NewsFeed - 21 Jun 2007
FDA Approves Ferring Pharmaceuticals' ENDOMETRIN(R) for Luteal Phase Support in Assisted Reproductive Technology Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jun 2007
Organon's Once-a-Month Contraceptive Ring, NuvaRing(R) Completes European Authorization
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Jun 2007
Inverness Medical Innovations Acquires Home Coagulation Service Provider, Quality Assured Services, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 11 Jun 2007
Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
Biopharmaceuticals

HSMN NewsFeed - 4 Jun 2007
Inverness Medical Innovations Agrees to Acquire Cholestech Corporation
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 31 May 2007
Halozyme Therapeutics Announces Closing of $32.1 Million Private Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 May 2007
FDA Approves Lybrel, First Low Dose Combination Oral Contraceptive Offering Women the Opportunity to Be Period-Free Over Time
Biopharmaceuticals FDA

HSMN NewsFeed - 17 May 2007
Inverness to Acquire Biosite via Cash Tender at $92.50 Per Share
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 17 May 2007
Inverness Medical Innovations and Procter & Gamble Form Consumer Diagnostics Joint Venture - SPD Swiss Precision Diagnostics GmbH
Diagnostics

HSMN NewsFeed - 16 May 2007
Medarex and Organon Announce Biotherapeutics Development Agreement
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 May 2007
Halozyme Therapeutics Names Randal J. Kirk and Kathryn E. Falberg to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2007
Hamilton Thorne Biosciences Announces Third-round FDA Marketing Clearance of its ZILOS-tk(R) Zona Laser Drill for Additional Clinical Applications of Blastomere Biopsy and Trophectoderm Biopsy
Devices FDA

HSMN NewsFeed - 14 May 2007
InSightec Encourages Uterine Fibroid Sufferers to Ask Their Doctors About Less Invasive Treatment Options
Devices

HSMN NewsFeed - 11 May 2007
Inverness Statement Regarding Cash Tender Offer at $92.50 Per Share
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 8 May 2007
Inverness Medical Innovations Acquires Benelux Distributor Orange Medical
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 8 May 2007
AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication
Biopharmaceuticals

HSMN NewsFeed - 7 May 2007
Early Results of the CellCept(R) Spare the Nephron Study Examine Kidney Function
Biopharmaceuticals

HSMN NewsFeed - 1 May 2007
OTN and Oncology Molecular Imaging Enter Into Exclusive Strategic Alliance Agreement to Offer Diagnostic Imaging and Radiation Therapy Services to Community-Based Oncologists
Devices Radiology Oncology

HSMN NewsFeed - 23 Apr 2007
Inverness Medical Innovations to Acquire Indian Distributor Spectral Diagnostics
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 10 Apr 2007
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 9 Apr 2007
Biosite Fails to Respond to Inverness' Superior Proposal of $90.00 Per Share in Cash
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 9 Apr 2007
OXIS International Expands Licensing Deal with Alteon to Include Exclusive Rights of Organoselenium Compounds for All Indications
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Apr 2007
Inverness Confirms Proposal to Acquire Biosite for $90.00 Per Share in Cash
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 20 Mar 2007
ViaCell Announces Commencement of ViaCyte Pivotal Trial
Regenerative Medicine

HSMN NewsFeed - 15 Mar 2007
Vitrolife: New Vice President Marketing & Sales
Devices Personnel

HSMN NewsFeed - 12 Mar 2007
Cangene receives an approvable letter from the FDA for human growth hormone
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Mar 2007
InSightec's ExAblate(R) 2000 Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) System is Approved for Sale in Canada
Devices Regulatory

HSMN NewsFeed - 12 Mar 2007
Schering-Plough to Acquire Organon BioSciences
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Mar 2007
Elbit Medical Group Announces FDA Approval of New Version of InSightec's ExAblate(R) 2000 That Speeds Up Treatment Time and the Use of ExAblate 2000 System With GE Healthcare's 3 Tesla Magnetic Resonance Imaging System
Devices FDA

HSMN NewsFeed - 1 Mar 2007
FDA Approves use of InSightec's ExAblate(R) 2000 With GE Healthcare's 3 Tesla Magnetic Resonance Imaging System
Devices FDA

HSMN NewsFeed - 1 Mar 2007
FDA Approves New Version of InSightec's ExAblate(R) 2000 That Speeds up Treatment Time
Devices FDA

HSMN NewsFeed - 28 Feb 2007
Symbollon Pharmaceuticals Receives Regulatory Guidance From Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Feb 2007
Bakri Postpartum Balloon Globally Acknowledged for Treatment of Postpartum Bleeding
Devices

HSMN NewsFeed - 20 Feb 2007
Vyteris Announces Senior Staff Promotions
Devices Drug Delivery Personnel

HSMN NewsFeed - 14 Feb 2007
Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX From the Infuse-Morphine Study
Biopharmaceuticals

HSMN NewsFeed - 14 Feb 2007
Halozyme and Baxter Expand Global HYLENEX Collaboration
Biopharmaceuticals

HSMN NewsFeed - 4 Feb 2007
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet Endpoints
Biopharmaceuticals

HSMN NewsFeed - 31 Jan 2007
Adeza Receives Orphan Drug Designation for Gestiva
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Jan 2007
Ikonisys Receives FDA Clearance for Automated Bladder Cancer Test
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 19 Jan 2007
Quest Diagnostics Announces Licensing Agreement for Genetic Testing Technology to Screen for Most Common Inherited Mental Impairment, Fragile X Syndrome
Diagnostics Licensing

HSMN NewsFeed - 16 Jan 2007
Synova Healthcare Group, Inc. Acquires Allendale Pharmaceuticals, Inc. and Exclusive Worldwide Rights to Today(R) Sponge
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Dec 2006
Inverness Medical Innovations and Procter & Gamble Sign Definitive Agreement to Form Consumer Diagnostics Joint Venture
Devices Diagnostics

HSMN NewsFeed - 14 Dec 2006
Nonsurgical Treatment for Arteriovenous Malformations
Devices Interventional Neurology Radiology

HSMN NewsFeed - 11 Dec 2006
Inverness Medical Innovations Appoints New Chief Financial Officer and Vice President, Finance
Diagnostics Personnel

HSMN NewsFeed - 7 Dec 2006
James Meer Appointed Chief Financial Officer of Columbia Laboratories
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2006
Halozyme and Roche Enter Agreement for the Application of Enhanze, A Novel Technology to Improve Drug Delivery
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 16 Nov 2006
Comprehensive Review Published on FzioMed Technology for Postsurgical Adhesion Prevention
Devices Surgery

HSMN NewsFeed - 8 Nov 2006
Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Nov 2006
Matritech and Inverness Medical Innovations Sign Agreements for the Manufacturing and OTC Distribution of the NMP22(R) BladderChek(R) Test
Diagnostics Oncology Distribution

HSMN NewsFeed - 26 Oct 2006
Aspreva Pharmaceuticals Announces Preliminary Results of Phase III Trial of CellCept for Myasthenia Gravis
Biopharmaceuticals

HSMN NewsFeed - 24 Oct 2006
Philips Announces Availability of Triplets Monitoring with Its Avalon Fetal Monitors; Company is first to introduce triplets monitoring using one fetal monitor
Devices Monitoring

HSMN NewsFeed - 23 Oct 2006
Adeza Receives FDA Approvable Letter for Gestiva
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Oct 2006
Gen-Probe Receives FDA Clearance to Run Standalone APTIMA(R) Tests for Chlamydia and Gonorrhea on the TIGRIS(R) System
Diagnostics FDA

HSMN NewsFeed - 16 Oct 2006
IP Chemotherapy, Combination Therapy for Cervical Cancer and IVF Treatment for Infertility
Biopharmaceuticals Drug Delivery Oncology

HSMN NewsFeed - 5 Oct 2006
Inverness Medical Innovations, Chembio Diagnostics, Inc. and StatSure Diagnostic Systems, Inc. Announce Agreements to Market Rapid HIV and Other Tests
Diagnostics

HSMN NewsFeed - 28 Sep 2006
Ikonisys Receives FDA Clearance for Prenatal Testing Application
Diagnostics FDA

HSMN NewsFeed - 21 Sep 2006
Broadlane and GENICON Introduce New Agreements Covering Endo-mechanical, Trocar, and Rigid Endoscopy Products
Devices Group Purchasing

HSMN NewsFeed - 21 Jul 2006
Exagen Diagnostics Names Luc Van Hove Vice President, Quality, Regulatory, Medical Affairs and Chief Medical Officer
Diagnostics Personnel

HSMN NewsFeed - 18 Jul 2006
FDA Approves IMPLANON(TM) (etonogestrel implant) 68mg, the First and Only Single-Rod Implantable Contraceptive
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 6 Jul 2006
FDA Accepts Adeza NDA Filing for Gestiva to Prevent Preterm Births
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Jun 2006
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
Biopharmaceuticals

HSMN NewsFeed - 23 May 2006
Halozyme Therapeutics Announces FDA 510(k) Clearance for MediCult's SynVitro Cumulase Product
Biopharmaceuticals FDA

HSMN NewsFeed - 10 May 2006
Unigene Enters into Exclusive Distribution Agreement for Fortical(R) Nasal Spray in Israel
Biopharmaceuticals Drug Delivery Distribution

HSMN NewsFeed - 9 May 2006
ETHICON, Inc. Completes Acquisition of Vascular Control Systems, Inc.
Devices Mergers & Acquisitions

HSMN NewsFeed - 8 May 2006
Cook Launches Women's Health Business Unit To Increase Quality of Life for Female Patients
Devices

HSMN NewsFeed - 5 May 2006
Irvine Scientific Launches Innovative In Vitro Fertilization Freezing Product, First in the World
Devices FDA

Return to NewsFeed

Additional items found! 171

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 171 additional stories matching:
fertility
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!